FSTX - F-star Therapeutics EPS misses by $7.92 beats on revenue March, 29 2021 09:17 AM F-star Therapeutics Inc Com F-star Therapeutics (FSTX): FY GAAP EPS of -$9.69 misses by $7.92.Revenue of $11.26M (-60.2% Y/Y) beats by $5.92M.Press Release For further details see: F-star Therapeutics EPS misses by $7.92, beats on revenue